%PDF- %PDF-
Mini Shell

Mini Shell

Direktori : /var/www/html/digiprint/public/site/trwzrk/cache/
Upload File :
Create Path :
Current File : /var/www/html/digiprint/public/site/trwzrk/cache/d0f51b14c583d9441b4a3245f50aea3c

a:5:{s:8:"template";s:7286:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Lato%3A300%2C400%7CMerriweather%3A400%2C700&amp;ver=5.4" id="siteorigin-google-web-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,header,nav{display:block}a{background-color:transparent}svg:not(:root){overflow:hidden}button{color:inherit;font:inherit;margin:0}button{overflow:visible}button{text-transform:none}button{-webkit-appearance:button;cursor:pointer}button::-moz-focus-inner{border:0;padding:0}html{font-size:93.75%}body,button{color:#626262;font-family:Merriweather,serif;font-size:15px;font-size:1em;-webkit-font-smoothing:subpixel-antialiased;-moz-osx-font-smoothing:auto;font-weight:400;line-height:1.8666}.site-content{-ms-word-wrap:break-word;word-wrap:break-word}html{box-sizing:border-box}*,:after,:before{box-sizing:inherit}body{background:#fff}ul{margin:0 0 2.25em 2.4em;padding:0}ul li{padding-bottom:.2em}ul{list-style:disc}button{background:#fff;border:2px solid;border-color:#ebebeb;border-radius:0;color:#2d2d2d;font-family:Lato,sans-serif;font-size:13.8656px;font-size:.8666rem;line-height:1;letter-spacing:1.5px;outline-style:none;padding:1em 1.923em;transition:.3s;text-decoration:none;text-transform:uppercase}button:hover{background:#fff;border-color:#24c48a;color:#24c48a}button:active,button:focus{border-color:#24c48a;color:#24c48a}a{color:#24c48a;text-decoration:none}a:focus,a:hover{color:#00a76a}a:active,a:hover{outline:0}.main-navigation{align-items:center;display:flex;line-height:1}.main-navigation:after{clear:both;content:"";display:table}.main-navigation>div{display:inline-block}.main-navigation>div ul{list-style:none;margin:0;padding-left:0}.main-navigation>div li{float:left;padding:0 45px 0 0;position:relative}.main-navigation>div li:last-child{padding-right:0}.main-navigation>div li a{text-transform:uppercase;color:#626262;font-family:Lato,sans-serif;font-size:.8rem;letter-spacing:1px;padding:15px;margin:-15px}.main-navigation>div li:hover>a{color:#2d2d2d}.main-navigation>div a{display:block;text-decoration:none}.main-navigation>div ul{display:none}.menu-toggle{display:block;border:0;background:0 0;line-height:60px;outline:0;padding:0}.menu-toggle .svg-icon-menu{vertical-align:middle;width:22px}.menu-toggle .svg-icon-menu path{fill:#626262}#mobile-navigation{left:0;position:absolute;text-align:left;top:61px;width:100%;z-index:10}.site-content:after:after,.site-content:before:after,.site-footer:after:after,.site-footer:before:after,.site-header:after:after,.site-header:before:after{clear:both;content:"";display:table}.site-content:after,.site-footer:after,.site-header:after{clear:both}.container{margin:0 auto;max-width:1190px;padding:0 25px;position:relative;width:100%}@media (max-width:480px){.container{padding:0 15px}}.site-content:after{clear:both;content:"";display:table}#masthead{border-bottom:1px solid #ebebeb;margin-bottom:80px}.header-design-2 #masthead{border-bottom:none}#masthead .sticky-bar{background:#fff;position:relative;z-index:101}#masthead .sticky-bar:after{clear:both;content:"";display:table}.sticky-menu:not(.sticky-bar-out) #masthead .sticky-bar{position:relative;top:auto}#masthead .top-bar{background:#fff;border-bottom:1px solid #ebebeb;position:relative;z-index:9999}#masthead .top-bar:after{clear:both;content:"";display:table}.header-design-2 #masthead .top-bar{border-top:1px solid #ebebeb}#masthead .top-bar>.container{align-items:center;display:flex;height:60px;justify-content:space-between}#masthead .site-branding{padding:60px 0;text-align:center}#masthead .site-branding a{display:inline-block}#colophon{clear:both;margin-top:80px;width:100%}#colophon .site-info{border-top:1px solid #ebebeb;color:#626262;font-size:13.8656px;font-size:.8666rem;padding:45px 0;text-align:center}@media (max-width:480px){#colophon .site-info{word-break:break-all}}@font-face{font-family:Lato;font-style:normal;font-weight:300;src:local('Lato Light'),local('Lato-Light'),url(http://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh7USSwiPHA.ttf) format('truetype')}@font-face{font-family:Lato;font-style:normal;font-weight:400;src:local('Lato Regular'),local('Lato-Regular'),url(http://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wWw.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:400;src:local('Merriweather Regular'),local('Merriweather-Regular'),url(http://fonts.gstatic.com/s/merriweather/v21/u-440qyriQwlOrhSvowK_l5-fCZJ.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:700;src:local('Merriweather Bold'),local('Merriweather-Bold'),url(http://fonts.gstatic.com/s/merriweather/v21/u-4n0qyriQwlOrhSvowK_l52xwNZWMf_.ttf) format('truetype')} </style>
 </head>
<body class="cookies-not-set css3-animations hfeed header-design-2 no-js page-layout-default page-layout-hide-masthead page-layout-hide-footer-widgets sticky-menu sidebar wc-columns-3">
<div class="hfeed site" id="page">
<header class="site-header" id="masthead">
<div class="container">
<div class="site-branding">
<a href="#" rel="home">
{{ keyword }}</a> </div>
</div>
<div class="top-bar sticky-bar sticky-menu">
<div class="container">
<nav class="main-navigation" id="site-navigation" role="navigation">
<button aria-controls="primary-menu" aria-expanded="false" class="menu-toggle" id="mobile-menu-button"> <svg class="svg-icon-menu" height="32" version="1.1" viewbox="0 0 27 32" width="27" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<path d="M27.429 24v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804zM27.429 14.857v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804zM27.429 5.714v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804z"></path>
</svg>
</button>
<div class="menu-menu-1-container"><ul class="menu" id="primary-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-20" id="menu-item-20"><a href="#">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-165" id="menu-item-165"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-24" id="menu-item-24"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-22" id="menu-item-22"><a href="#">Contacts</a></li>
</ul></div> </nav>
<div id="mobile-navigation"></div>
</div>
</div>
</header>
<div class="site-content" id="content">
<div class="container">
{{ text }}
<br>
{{ links }}
</div>
</div>
<footer class="site-footer " id="colophon">
<div class="container">
</div>
<div class="site-info">
<div class="container">
{{ keyword }} 2021</div>
</div>
</footer>
</div>
</body>
</html>";s:4:"text";s:17492:"On May 20, 2021, the Board of Directors (the "Board") of Accelerate Diagnostics, Inc. (the "Company") elected Hany Massarany as a member of the Board, effective immediately. Menu options for Accelerate Diagnostics Inc. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. The average adjusted close price of AXDX last month was 9.03$. Stock Awards: Compensation paid in the form of company equity that is structured as restricted stock. The company report on January 12, 2021 that Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full … Find real-time AXDX - Accelerate Diagnostics Inc stock quotes, company profile, news and forecasts from CNN Business. Accelerate Diagnostics, Inc. is an in-vitro diagnostics company providing solutions to improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. FOR SECTION 16 REPORTING OBLIGATIONS . Accelerate Diagnostics, Inc. (NASDAQ:AXDX)’s Biggest Investors. Find out what works well at Accelerate Diagnostics Inc. from the people who know best. Explore commentary on Accelerate Diagnostics, Inc… Insider trades for Accelerate Diagnostics, Inc (AXDX). Company Releases for Accelerate Diagnostics Inc. Thursday, May 20, 2021. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. Accelerate Diagnostics, Inc. Common Stock (AXDX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. View the latest Accelerate Diagnostics Inc. (AXDX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Additional information is available upon request. View today's stock price, news and analysis for Accelerate Diagnostics Inc. (AXDX). Becton, Dickinson and Company NYSE: BDX $258.21 up $0.76 (0.29%) DHR. Global Antimicrobial Susceptibility Testing Market Size, Share, Value, And Competitive Landscape 2021-2026 Heraldkeepers. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. Mr. Massarany has been appointed to the Nominating and Governance … This plan is in the top 15% of plans for Salary Deferral. 1 Accelerate Diagnostics Inc (AXDX) Stock Price Last Month. Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. accelerate diagnostics sees q4 2020 revenue about $3.1 million. Real-time Insider Trading Stock Screener. Accelerate Diagnostics, Inc. 401k Plan currently has over 200 active participants and over $5.3M in plan assets. Find 17 available jobs at Accelerate Diagnostics, Inc with Ladders. Accelerate Diagnostics is not a large company by global standards. Find the latest Accelerate Diagnostics, Inc. (AXDX) stock quote, history, news and other vital information to help you with your stock trading and investing. 02:41 PM ET. Get the latest Accelerate Diagnostics, Inc. AXDX detailed stock quotes, … Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. Business Description Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The fund owned 1,097,419 shares of the medical research company’s stock after selling 15,820 shares during the quarter. The latest litigation news involving the company Accelerate Diagnostics Inc. (NASDAQ:AXDX) Oracle Investment Management Inc is the largest shareholder of the company, while 166 institutions own stock in it. Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to … Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that carries out the development and commercialization of instruments for the identification and testing of antibiotic susceptibility of infectious pathogens. TUCSON, Ariz., March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to … Thanks to fractional shares , you can buy Accelerate Diagnostics Inc stock in any dollar amount, or … Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. Accelerate Diagnostics Inc currently has the 42th highest Short-Term Technical score in the Diagnostics & Research industry. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Company develops diagnostic systems for bacterial infections. Come join us in the fight against COVID-19! Laura Pierson - Investor Relations. C/O ACCELERATE DIAGNOSTICS, INC. 3950 S. COUNTRY CLUB ROAD, SUITE 470 (Street) TUCSON: AZ: 85714 (City) (State) (Zip) 2. The chart on this page features a breakdown of the total annual pay for Jack Schuler at ACCELERATE DIAGNOSTICS INC as reported in their proxy statements.. Fees Earned or Paid in Cash: This is the amount of fixed retainers and meeting fees and paid in the form of cash. The Tucson, Arizona-based company said it … Mr. Phillips joined the company in September of 2019 as Chief Operating Officer. AXDX stock rating and analysis - Accelerate Diagnostics Inc : a summary of key financial strength and profitability metrics. Accelerate Diagnostics Inc is an in vitro diagnostics company that specializes in rapid diagnostics for infectious pathogens. AXDX 7.17 0.06 (0.83%). It has a market capitalization of US$513m, which means it wouldn't have the attention of many institutional investors. Accelerate Diagnostics, Inc. 401k Plan is a defined contribution plan with a profit-sharing component and 401k feature. Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Market forces rained on the parade of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) shareholders today, when the analysts downgraded their forecasts for … Set to grow by USD 2.11 billion during 2021-2025, Technavio's latest market research report estimates the allergy diagnostics market to register a CAGR of almost 12%. This figure is a simple daily average by dividing the sum of adj closes by the number of market working days in Mar 2021.  Get the latest Accelerate Diagnostics, Inc. AXDX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Accelerate Diagnostics: DEN160032, DEN160032/S001: Great Basin Staph ID/R Blood Culture Panel: Great Basin Scientific, Inc. K152470, K152470/S001: hemoFISH Masterpanel: Miacom Diagnostics GMBH: Accelerate Diagnostics Inc (AXDX) latest news, insider trading and hedge fund ownership data provided by Insider Monkey. Stock Awards: Compensation paid in the form of company equity that is structured as restricted stock. News for Accelerate Diagnostics Inc. Friday, September 27, 2019. Inventors: Steven W. Metzger, David C. Howson, David A. Goldberg, Daniel A. Buttry INSTRUMENT AND SYSTEM FOR RAPID MICROORGANISM IDENTIFICATION AND ANTIMICROBIAL AGENT SUSCEPTIBILITY TESTING. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Company Releases for Accelerate Diagnostics Inc. Thursday, May 20, 2021. Accelerate Diagnostics Inc NASDAQ Updated May 21, 2021 8:00 PM. Accelerate Diagnostics, Inc. NASDAQ: AXDX $8.08 down $0.27 (-3.23%) BDX. The chart on this page features a breakdown of the total annual pay for Thomas D. Brown at ACCELERATE DIAGNOSTICS INC as reported in their proxy statements.. Fees Earned or Paid in Cash: This is the amount of fixed retainers and meeting fees and paid in the form of cash. View detailed financial information, real-time news, videos, quotes and analysis on Accelerate Diagnostics, Inc. (NASDAQ:AXDX). Stock analysis for Accelerate Diagnostics Inc (AXDX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. From 2010 to 2019, Mr. Phillips served as President and CEO of Roche Diagnostics North America, the world leader in in-vitro diagnostics. The 1-year high price for the company’s stock is recorded $13.00 on 01/25/21, with the lowest value was $7.42 for the same time period, recorded on 01/04/21. Accelerate Diagnostics to Participate in William Blair 41st Annual Growth Stock Conference on June 3, 2021 PR Newswire TUCSON, Ariz., May 19, 2021 TUCSON, Ariz. , May 19, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Chief Executive Officer, Jack Phillips , and Chief Financial Officer, Steve Reichling , will present virtually at the William … Accelerate Diagnostics, Inc. Common Stock (AXDX) Nasdaq 9/14/2019 Accelerate Diagnostics to Host Call to Review First Quarter 2021 Results Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Find high paying available jobs at Accelerate Diagnostics, Inc.For expert network information on Accelerate Diagnostics, Inc compensation and careers, use Ladders $100K + Club. Accelerate Diagnostics Inc. (“Accelerate Diag­ nostics”) is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and health­ care­associated infections. Accelerate Diagnostics Inc. (AXDX) had a good day on the market for Wednesday December 30 as shares jumped 1.78% to close at $7.45. Accelerate Diagnostics, Inc. was founded in 1982 and is headquartered in Tucson, Arizona. Accelerate Diagnostics Inc. (NASDAQ: AXDX) stock closed at 7.17 per share at the end of the most recent trading day (a -0.83 % change compared to the prior day closing price) with a volume of 159.85K shares and market capitalization of 437.69M.Is a component of indices and it is traded on NASDAQ exchange. Our calculations showed that top … Accelerate Diagnostics Inc Stock (NASDAQ) AXDX Dividend policy None Price as of: MAY 17, 07:26 AM EDT $7.07 +0.07 +1.0% AXDX: NASDAQ (Stock) Accelerate Diagnostics Inc Dividend policy None Price as of: MAY 17, 07:26 AM EDT $7.07 +0.07 +1.0% AXDX: NASDAQ (Stock) Accelerate Diagnostics Inc Accelerate Diagnostics To Participate In BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference On February 18, 2020, At 4:00 P.m. Eastern Time By PR Newswire Feb 1, 2021 8:00 AM EST Wednesday, November 07, 2018 Cannell Peter B & Co. Inc. decreased its position in shares of Accelerate Diagnostics, Inc. (NASDAQ:AXDX) by 1.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The stock of Accelerate Diagnostics (NAS:AXDX, 30-year Financials) is believed to be possible value trap, according to GuruFocus Value calculation.GuruFocus Value is GuruFocus' estimate of the fair value at which the stock should be traded. Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. Accelerate Diagnostics, Inc. Dec 2017 - Present 3 years 2 months. AXDX's rank also includes a short-term technical score of 10. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential misconduct at Accelerate Diagnostics, Inc. (“Accelerate Diagnostics” or the “Company”) (NASDAQ: AXDX). Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and … The company belongs in the Medical Diagnostics & Research industry, Healthcare … The FDA cleared … KDx Diagnostics Inc., located in Campbell, CA, USA, has developed a non-invasive urine test, URO17 ® that has shown high accuracy detection of … Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and healthcare-associated infections. Two analysts have issued estimates for Accelerate Diagnostics’ earnings, with the highest sales estimate coming in at $3.90 million and the lowest estimate coming in at $3.20 million. Uncover why Accelerate Diagnostics Inc. is the best company for you. Accelerate Diagnostics, Inc. (Accelerate) today announced that the U.S. Food and Drug Administration has granted the de novo request to market the Accelerate Pheno™ system and Accelerate PhenoTest™ BC kit for identification and antibiotic susceptibility testing of pathogens directly from positive blood culture samples. TUCSON, Ariz., Feb. 1, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that management will host a conference call on Tuesday, February 23, 2021, at 4:30 p.m. Eastern Time to review 2020 fourth quarter and full year financial results. View Accelerate Diagnostics, Inc. AXDX investment & stock information. Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. TUCSON, Ariz. (AP) _ Accelerate Diagnostics Inc. (AXDX) on Thursday reported a loss of $24.2 million in its first quarter. To … Jack Phillips - … 07:23 AM ET. Accelerate Diagnostics is a medical device company dedicated to providing solutions to the global challenge of drug-resistant organisms and hospital-acquired infections. View Accelerate Diagnostics, Inc. AXDX investment & stock information. Business Description Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Get the latest Accelerate Diagnostics Inc (AXDX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. 04:37 AM ET Taking a look at our data on the ownership groups (below), it seems that institutional investors have bought into the company. Thanks to fractional shares , you can buy Accelerate Diagnostics Inc stock in any dollar amount, or … … Statutory losses were US$0.33 a share, in line with what the analysts predicted. Accelerate Diagnostics, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-31822 84-1072256 (Commission File Number) (IRS Employer Identification No.) Accelerate Diagnostics Inc. News & Case Alert on Accelerate Diagnost... Healthcare » Diagnostic Substances » Accelerate Diagnostics Inc. New Cases Alert. It is calculated based on the historical multiples that the stock has traded at, the past business growth and analyst estimates of future business performance. 04:37 AM ET Please contact us at +1 800 621 0687 or view disclosures on our coverage list. A brief summary - strong Buy, Buy, strong Sell, Sell or Neutral signals for the Accelerate Diagnostics Inc stock. The third-quarter results for Accelerate Diagnostics, Inc. (NASDAQ:AXDX) were released last week, making it a good time to revisit its performance.The business exceeded revenue expectations with sales of US$3.6m coming in 9.9% ahead of forecasts. 2017-11-16: EX-3.1 Accelerate Diagnostics serves … It also develops and licenses OptiChem surface coatings for use in microarraying … Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2020 Results Earnings Conference Call February 23, 2021 4:30 PM ET Company Participants. Elkridge, MD Commercial Development Director Accelerate Diagnostics, Inc. Sep 2015 - Dec 2017 2 years 4 months. ";s:7:"keyword";s:27:"accelerate diagnostics, inc";s:5:"links";s:1172:"<a href="http://digiprint.coding.al/site/trwzrk/schedule-python-script-to-run-daily">Schedule Python Script To Run Daily</a>,
<a href="http://digiprint.coding.al/site/trwzrk/london%27s-burning-series-10">London's Burning Series 10</a>,
<a href="http://digiprint.coding.al/site/trwzrk/what-are-word-parts-in-medical-terminology">What Are Word Parts In Medical Terminology</a>,
<a href="http://digiprint.coding.al/site/trwzrk/ariana-grande-college">Ariana Grande College</a>,
<a href="http://digiprint.coding.al/site/trwzrk/how-much-is-the-pappas-family-worth">How Much Is The Pappas Family Worth</a>,
<a href="http://digiprint.coding.al/site/trwzrk/evernote-keyboard-shortcuts-2020">Evernote Keyboard Shortcuts 2020</a>,
<a href="http://digiprint.coding.al/site/trwzrk/is-cirino%27s-in-grass-valley-open">Is Cirino's In Grass Valley Open</a>,
<a href="http://digiprint.coding.al/site/trwzrk/iowa-snow-storm-today">Iowa Snow Storm Today</a>,
<a href="http://digiprint.coding.al/site/trwzrk/son-goal-vs-burnley-korean-commentary">Son Goal Vs Burnley Korean Commentary</a>,
<a href="http://digiprint.coding.al/site/trwzrk/drag-queen-games-online">Drag Queen Games Online</a>,
";s:7:"expired";i:-1;}

Zerion Mini Shell 1.0